General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0GKDOB
ADC Name
PLBA-002
Synonyms
PLBA 002; PLBA002
   Click to Show/Hide
Organization
PrimeLink BioTherapeutics (Suzhou) Co., Ltd.; PrimeLink BioTherapeutics (Shenzhen) Co., Ltd.
Drug Status
Investigative
Indication
In total 1 Indication(s)
Ovarian cancer [ICD11:2C73]
Investigative
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.